Literature DB >> 27813155

Risk and Prevention of Fracture in Patients With Major Medical Illnesses: A Mini-Review.

Steven R Cummings1, Richard Eastell2.   

Abstract

Patients with several medical conditions, including Parkinson's disease, recent stroke, HIV, and heart failure, have a high risk of hip fracture. These patients will also have more severe consequences of a hip fracture, including a greater chance of dying and more prolonged disability. Together, there are nearly as many patients with medical conditions that substantially increase the risk of hip fracture as there are people with osteoporosis by femoral neck bone mineral density (BMD). The contributions of falling and decreased bone mass to the increased risks with these conditions are not certain. Although there are few data about whether and what type of treatments these patients receive to prevent fracture, it is likely that few receive pharmacologic treatments that have been shown to reduce the risk of hip fracture. There is a need to show that drug treatments that strengthen bone also reduce fracture risk in patients whose risk may be owing in greater part to traumatic falls than osteoporosis. Assuming that treatments are efficacious in these patients, there is a major opportunity to substantially reduce the incidence and consequences of hip fracture by reaching more of them with drug treatments to reduce the risk of hip fracture. This will require engagement of specialists who have little expertise and perhaps limited interest in preventing fractures, or new approaches to delivering drug treatments to prevent fracture directly to the patients at risk.
© 2016 American Society for Bone and Mineral Research. © 2016 American Society for Bone and Mineral Research.

Entities:  

Mesh:

Year:  2016        PMID: 27813155     DOI: 10.1002/jbmr.3030

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  11 in total

1.  Impact of Competing Risk of Mortality on Association of Cognitive Impairment With Risk of Hip Fracture in Older Women.

Authors:  Susan J Diem; Tien N Vo; Lisa Langsetmo; John T Schousboe; Kristine Yaffe; Kristine E Ensrud
Journal:  J Bone Miner Res       Date:  2018-09       Impact factor: 6.741

2.  Chlorpyrifos Exposure Induces Parkinsonian Symptoms and Associated Bone Loss in Adult Swiss Albino Mice.

Authors:  Shaheen Jafri Ali; Govindraj Ellur; Kalpana Patel; Kunal Sharan
Journal:  Neurotox Res       Date:  2019-07-31       Impact factor: 3.911

3.  Parkinson's disease and osteoporosis: basic and clinical implications.

Authors:  Carolina A Figueroa; Clifford J Rosen
Journal:  Expert Rev Endocrinol Metab       Date:  2020-04-26

4.  Long-term effects of functional impairment on fracture risk and mortality in postmenopausal women.

Authors:  T Rikkonen; K Poole; J Sirola; R Sund; R Honkanen; H Kröger
Journal:  Osteoporos Int       Date:  2018-06-02       Impact factor: 4.507

5.  Sociodemographic and health system factors associated with variations in hospitalization costs for fractures in adults aged 45 years and over: a cross-sectional study of provincial health accounts in Jiangsu Province, China.

Authors:  Lizheng Xu; Stephen Jan; Mingsheng Chen; Lei Si
Journal:  Arch Osteoporos       Date:  2021-10-04       Impact factor: 2.617

6.  Role of microRNA-335 carried by bone marrow mesenchymal stem cells-derived extracellular vesicles in bone fracture recovery.

Authors:  Haifeng Hu; Dong Wang; Lihong Li; Haiyang Yin; Guoyu He; Yonghong Zhang
Journal:  Cell Death Dis       Date:  2021-02-04       Impact factor: 8.469

Review 7.  Skeleton-vasculature chain reaction: a novel insight into the mystery of homeostasis.

Authors:  Ming Chen; Yi Li; Xiang Huang; Ya Gu; Shang Li; Pengbin Yin; Licheng Zhang; Peifu Tang
Journal:  Bone Res       Date:  2021-03-22       Impact factor: 13.567

8.  Thiazide diuretics and the risk of hip fracture after stroke: a population-based propensity-matched cohort study using Taiwan's National Health Insurance Research Database.

Authors:  Shu-Man Lin; Shih-Hsien Yang; Hung-Yu Cheng; Chung-Chao Liang; Huei-Kai Huang
Journal:  BMJ Open       Date:  2017-09-27       Impact factor: 2.692

9.  Pine needles attenuate receptor activator for nuclear factor-B ligand (RANKL)-induced trabecular bone loss by inhibiting osteoclast differentiation.

Authors:  Ki-Shuk Shim; Jin Yeul Ma
Journal:  Integr Med Res       Date:  2018-07-03

Review 10.  Exosomes: A Friend or Foe for Osteoporotic Fracture?

Authors:  Zhimin Yang; Wenchao Zhang; Xiaolei Ren; Chao Tu; Zhihong Li
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-21       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.